Dr. Rémi LeBlanc specializes in internal medicine, intensive care, organ donation, and gastroenterology. DGLDUHC is a designated university hospital centre and is supported by the Vitalité Health Network’s Clinical Trials Support Unit. This Network collaborates with the Centre de Formation Médicale du Nouveau-Brunswick (affiliated with Université de Moncton and Université de Sherbrooke), the New Brunswick Centre for Precision Medicine, the Atlantic Cancer Research Institute, and is part of the Atlantic Clinical Trials Network (ACTN). Research areas of interest include oncology, respirology, cardiology, neurology, critical care, nephrology, infectious diseases, emergency medicine, and mental health.


Canadian Chronic Airway Disease Network (CCADN), Canadian COVID-19 Emergency Department Rapid Response Network (CEDRRN), Canadian Critical Care Trials Group (CCCTG), Canadian Heart Function Alliance (CHF), Canadian Immunization Research Network (CIRN), Canadian Nephrology Trials Network (CNTN), Canadian Research Network for Adult Congenital Heart Disease Interventions (CRN-ACHDi, Canadian Stroke Consortium (CSC), Canadian Stroke Prevention Intervention Network (CSPIN), CanStroke Recovery Trials, Cardiac Arrhythmia Network of Canada (CANet), Infectious Disease Network, Interventional Cardiology Network, Ontario Clinical Oncology Group, Pan-Canadian Trial Network in Valvular Heart Disease (PACT-V Heart Valve Network)